title: Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro.
abstract: Treatment with bismuth-containing remedies has been long associated with the alleviation of minor gastric ailments. Bismuth salts have a potent antimicrobial activity, and are part of the current standard regime used to treat Helicobacter pylori infection. H. pylori is considered to be the major etiological factor in the development of peptic ulcer disease. Earlier efficacious treatments for peptic ulcer included the oral administration of Tween detergents. We have found that these agents have an inhibitory effect on H. pylori adhesion to the lipid species phosphatidylethanolamine (PE) and gangliotetraosylceramide (Gg4) shown previously to be receptors for H. pylori binding in vitro. H. pylori binding to PE and Gg4 was inhibited after a thirty minute preincubation with different bismuth compounds: bismuth subsalicylate > bismuth subgallate > bismuth carbonate > colloidal bismuth subcitrate > tripotassium dicitrato bismuthate. No inhibitory effect on H. pylori binding was observed when bismuth salts were added directly into the binding assay. No changes in bacterial morphology and motility were observed after the thirty minute incubation. Pretreatment with Tween detergents also inhibited H. pylori receptor binding by up to 80% at concentrations as low as 0.0001%. These results suggest that inhibition of H. pylori/host cell adhesion might play a role in efficacious treatment for this infection.
authors.affiliation: Department of Microbiology, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Huesca
authors.forename: B
authors.initials: B
authors.lastname: Gold
authors.forename: P
authors.initials: P
authors.lastname: Sherman
authors.forename: P
authors.initials: P
authors.lastname: Lewin
authors.forename: C
authors.initials: C
authors.lastname: Lingwood
mesh_terms: D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001422:Bacterial Adhesion / Q000187:drug effects*; D001729:Bismuth / Q000494:pharmacology; D002240:Carbohydrate Sequence; D003902:Detergents / Q000494:pharmacology; D005732:Gangliosides; D006028:Glycosphingolipids / Q000378:metabolism; D016480:Helicobacter pylori / Q000187:drug effects* / Q000378:metabolism; D008969:Molecular Sequence Data; D010437:Peptic Ulcer / Q000188:drug therapy; D010714:Phosphatidylethanolamines / Q000378:metabolism
chemical_list: D000897:Anti-Ulcer Agents; D003902:Detergents; C011258:G(A1) ganglioside; D005732:Gangliosides; D006028:Glycosphingolipids; D010714:Phosphatidylethanolamines; D001729:Bismuth